Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9257898rdf:typepubmed:Citationlld:pubmed
pubmed-article:9257898lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:9257898lifeskim:mentionsumls-concept:C0149615lld:lifeskim
pubmed-article:9257898lifeskim:mentionsumls-concept:C0155765lld:lifeskim
pubmed-article:9257898lifeskim:mentionsumls-concept:C0019054lld:lifeskim
pubmed-article:9257898pubmed:issue3lld:pubmed
pubmed-article:9257898pubmed:dateCreated1997-9-23lld:pubmed
pubmed-article:9257898pubmed:abstractTextThrombotic microangiopathy (TMA) is one of the complications of bone marrow transplantation (BMT) which includes hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic purpura (TTP). Red cell fragmentation is the most consistent laboratory finding. We present a case of TMA with endothelial damage but without the signs of hemolysis. The patient was not receiving cyclosporine. Partial activation of platelets was also observed. This case represents a new form of TMA in transplant recipients.lld:pubmed
pubmed-article:9257898pubmed:languageenglld:pubmed
pubmed-article:9257898pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9257898pubmed:citationSubsetIMlld:pubmed
pubmed-article:9257898pubmed:statusMEDLINElld:pubmed
pubmed-article:9257898pubmed:monthAuglld:pubmed
pubmed-article:9257898pubmed:issn0268-3369lld:pubmed
pubmed-article:9257898pubmed:authorpubmed-author:YoshinagaHHlld:pubmed
pubmed-article:9257898pubmed:authorpubmed-author:SakamakiHHlld:pubmed
pubmed-article:9257898pubmed:authorpubmed-author:AkiyamaHHlld:pubmed
pubmed-article:9257898pubmed:authorpubmed-author:OnozawaYYlld:pubmed
pubmed-article:9257898pubmed:authorpubmed-author:TanoueKKlld:pubmed
pubmed-article:9257898pubmed:authorpubmed-author:EndouMMlld:pubmed
pubmed-article:9257898pubmed:authorpubmed-author:TanikawaSSlld:pubmed
pubmed-article:9257898pubmed:issnTypePrintlld:pubmed
pubmed-article:9257898pubmed:volume20lld:pubmed
pubmed-article:9257898pubmed:ownerNLMlld:pubmed
pubmed-article:9257898pubmed:authorsCompleteYlld:pubmed
pubmed-article:9257898pubmed:pagination261-3lld:pubmed
pubmed-article:9257898pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:9257898pubmed:meshHeadingpubmed-meshheading:9257898-...lld:pubmed
pubmed-article:9257898pubmed:meshHeadingpubmed-meshheading:9257898-...lld:pubmed
pubmed-article:9257898pubmed:meshHeadingpubmed-meshheading:9257898-...lld:pubmed
pubmed-article:9257898pubmed:meshHeadingpubmed-meshheading:9257898-...lld:pubmed
pubmed-article:9257898pubmed:meshHeadingpubmed-meshheading:9257898-...lld:pubmed
pubmed-article:9257898pubmed:meshHeadingpubmed-meshheading:9257898-...lld:pubmed
pubmed-article:9257898pubmed:meshHeadingpubmed-meshheading:9257898-...lld:pubmed
pubmed-article:9257898pubmed:meshHeadingpubmed-meshheading:9257898-...lld:pubmed
pubmed-article:9257898pubmed:meshHeadingpubmed-meshheading:9257898-...lld:pubmed
pubmed-article:9257898pubmed:year1997lld:pubmed
pubmed-article:9257898pubmed:articleTitleMicroangiopathy without hemolysis in a patient following allogeneic bone marrow transplantation.lld:pubmed
pubmed-article:9257898pubmed:affiliationHematology Division, Tokyo Metropolitan Komagome Hospital, Bunkyo-ku, Japan.lld:pubmed
pubmed-article:9257898pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9257898pubmed:publicationTypeCase Reportslld:pubmed